Figure 1From: Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy Plasma concentrations of oxaliplatin and azacitidine. (a) Pharmacokinetic results for oxaliplatin. (b) Pharmacokinetic results for azacitidine.Back to article page